What is Low Level Laser Therapy?
Low Level Laser Therapy (LLLT), also known as or Cold Laser Therapy, is a non-invasive, pain-free treatment utilizing specific wavelengths of light to stimulate cellular activity and promote natural healing processes.
Erchonia’s state-of-the-art LLLT devices deliver targeted, low-intensity laser beams to the affected tissue, enhancing cell metabolism, reducing inflammation, and accelerating tissue repair. Widely used for pain management, wound healing, and various musculoskeletal conditions, Erchonia’s LLLT offers a safe, effective, and drug-free solution for patients seeking relief and improved quality of life.
Pain Relief
Pain is a powerful motivation to take action!
At Island Chiropractic, we understand pain relief is one of your primary goals, which is why we offer Erchonia laser therapy to help you feel better faster!
Erchonia’s non-thermal, Low-Level Laser Therapy (LLLT) devices are the most effective, versatile, and clinically proven technologies for pain relief.
The efficacy of our devices has been proven by multiple (level 1) double-blind, randomized, placebo-controlled, and multi-site clinical studies – the most credible research in the market today. The treatments are short, effective, and easy to administer, saving time and minimizing physical exertion. There is no associated pain or reported side effects, and the technology is very safe with no health risks.
“Erchonia Laser Therapy has helped me walk again with less pain.”
— Anonymous
Most Credible Research in the Market
Clinical research is the generic name given to the branch of medical science that determines the safety and effectiveness of medications, devices, diagnostic products, and treatment regimens intended for human use. The term refers to the entire biography of its focus, whether a method, application, and/or device, covering the process through the concept, feasibility, and viability phases. Clinical research is conducted with a specific goal in mind – for Erchonia® Corporation, it is the advancement of Low-Level Laser Therapy (LLLT).
Research sponsored by Erchonia® begins with a concept, identified as an area where low-level laser application can have a benefit. The management of Erchonia® Corporation, and a benchmark group of physicians in the field of practice associated with the area, define the scope of a study. The pilot study is launched and worked with the benchmark group of physicians. Results that reach a specific milestone are assessed and feasibility is determined. Once deemed feasible, a formal clinical trial protocol is developed. Erchonia® works through an Investigational Review Board to ensure the protocol is acceptable to the FDA.
Clinical trials, depending on their scope, can take years to conduct. Erchonia® Corporation makes this investment, as clinical trials are the foundational component of 510(k) submissions. Not all clinical trials result in market clearance by the FDA, and not all FDA clearance is dependent on the submitter’s clinical data. However, Erchonia® is committed to advance Laser Healthcare™ through sponsored clinical trials, as doing so ensures the protocols are developed by Erchonia®, making Erchonia®, and the physicians working on our behalf, the most knowledgeable to teach the protocol, and making protocols themselves and intellectual assets patentable.
The following list shows the clinical trials as related to chiropractic and an outline of their progress. As a company, to protect our intellectual assets, not all clinical trials we are involved with are made public so as to protect our competitive advantage. As such, not all clinical trials are listed below.
1) Chronic Neck and Shoulder Pain / Low Level Laser — 2000 — Sponsor and monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study.
First study done in support of 510(k) submission, second study requested by FDA.
2) Chronic Neck and Shoulder Pain / Low Level Laser — 2001 — Sponsor and monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study.
Study results used to obtain FDA clearance – K012580To view NIH clinical trial records, click here.
3) Acne Vulgaris — Dermatological Conditions / Low Level Laser — 2005 — Sponsor and monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study.
FDA clearance – K050672
4) Adjunct to Chronic Heel Pain Arising from Plantar Fasciitis Using the Erchonia FX635 Laser — 2012 — Sponsor and monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study.
FDA clearance – K132940Study results published in the American Orthopaedic Foot & Ankle Society April 2014To view NIH clinical trial records, click here.
5) Erchonia EVRL (EVRL) – 2016
a. while using the red diode, for adjunctive use in providing temporary relief of minor chronic neck and shoulder pain of musculoskeletal origin.
b. and while using the violet diode, to treat dermatological conditions, and specifically indicated to treat moderate inflammatory Acne Vulgaris.
FDA clearance – K152196
6) Market Clearance to Treat Chronic Low Back Pain (FX 635) — 2018 — Placebo-controlled, randomized, double-blind, parallel-group, multi-center clinical study.
FDA clearance – K180197To view NIH clinical trial records, click here.
7) Market Clearance for Relief of Chronic Musculoskeletal Pain (FX 635) — 2019 — A collection of placebo-controlled, randomized, double-blind, parallel-group, multi-center clinical studies.
FDA clearance – K190572